Literature DB >> 19454171

Transfection efficiency of 25-kDa PEI-cholesterol conjugates with different levels of modification.

Olesya Gusachenko Simonova1, Youlia Kravchuk, Dmitriy Konevets, Vladimir Silnikov, Valentin V Vlassov, Marina A Zenkova.   

Abstract

This report describes lipophilic conjugates of 25-kDa polyethylenimine (PEI) designed to provide better vectors for nucleic acid transfection. Conjugation of cholesterol is known both to improve transfection properties of PEIs and to reduce their cytotoxic effect. However, extensive modification would significantly decrease the polymer overall positive charge, resulting in less efficient condensation and poor delivery of nucleic acids into cells. In this study we tried to find the optimal modification extent of the PEI carrier, 25 kDa PEI, with cholesterol. Conjugates of PEI having a different number of cholesterol residues attached to their amines (5-20% of amines were modified) were synthesized. The conjugates were tested in vitro in transfection experiments, which have been carried out in the presence and in the absence of 10% FBS. Transfection efficiency studies were performed using different types of biologically active nucleic acids: single-stranded oligonucleotide, plasmid expressing vector and small interfering RNA duplex, under conditions close to those routinely applied for each type of delivered nucleic acid. PEI-cholesterol conjugates were applied at concentrations below the level at which the cytotoxic activity was observed. Results of this study demonstrate that efficient transfection and lower toxicity of the compounds is achieved at 1% modification of amino groups of the polymer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454171     DOI: 10.1163/156856209X444448

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  7 in total

1.  Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery.

Authors:  Rupa R Sawant; Shravan Kumar Sriraman; Gemma Navarro; Swati Biswas; Riddhi A Dalvi; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-02-25       Impact factor: 12.479

2.  Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

Authors:  Swati Biswas; Pranali P Deshpande; Gemma Navarro; Namita S Dodwadkar; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-11-05       Impact factor: 12.479

3.  P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells.

Authors:  Gemma Navarro; Rupa R Sawant; Swati Biswas; Sean Essex; Conchita Tros de Ilarduya; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2012-01       Impact factor: 5.307

4.  Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery.

Authors:  Gemma Navarro; Rupa R Sawant; Sean Essex; Conchita Tros de Ilarduya; Vladimir P Torchilin
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

5.  Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers.

Authors:  Ajit Thakur; Scott Fitzpatrick; Abeyat Zaman; Kapilan Kugathasan; Ben Muirhead; Gonzalo Hortelano; Heather Sheardown
Journal:  J Biol Eng       Date:  2012-06-11       Impact factor: 4.355

6.  Effect of PEGylation on assembly morphology and cellular uptake of poly ethyleneimine-cholesterol conjugates for delivery of sorafenib tosylate in hepatocellular carcinoma.

Authors:  Maryam Monajati; Shirin Tavakoli; Samira Sadat Abolmaali; Gholamhossein Yousefi; AliMohammad Tamaddon
Journal:  Bioimpacts       Date:  2018-04-18

7.  Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery.

Authors:  Ashita Nair; Jiyoon Bu; Jason Bugno; Piper A Rawding; Luke J Kubiatowicz; Woo-Jin Jeong; Seungpyo Hong
Journal:  Biomacromolecules       Date:  2021-07-28       Impact factor: 6.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.